Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Consider two people who both lose 15 kilograms on a GLP-1 drug: Lost 15 kg but poorly 10 kg fat lost 5 kg muscle lost Metabolic rate has fallen Blood sugar control worsened Higher fall risk than before Weight regain likely as fat Lost 15 kg and well 14 kg fat lost 1 kg muscle lost (or neutral) Metabolic rate preserved Blood sugar control improved Strength maintained or increased Better long-term weight maintenance Both people lost the same amount of weight by the scale
Cumulative food intake and body weight change were assessed 24 h post-injections
GLP-1R (glucagon-like peptide-1 receptor) agonists are approved for the treatment of diabetes and obesity
Following a healthy diet and exercise plan recommended by your healthcare provider will help to maintain your results if you decide to stop
Endocrine 62(3):535545
(2022, December 30)
US$ 20.88
US$ 22.97
)
US$ 25.71
